|
Index of reports
> Cases resulting in death (5)
> Cases with Ventricular Fibrillation (1)
Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in death where reactions include ventricular fibrillation.
Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from South Africa on 2007-02-20
Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Back Pain, Guillain-Barre Syndrome, Nausea, Hypotension, Muscular Weakness, Organ Failure, Brain Oedema, Dizziness, Pulmonary Oedema, Cytomegalovirus Infection, Respiratory Arrest, Ventricular Fibrillation, Cardiac Arrest, Muscle Spasms, Lung Injury
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Botox
Dosage: 22 units, single
Indication: Skin Wrinkling
Start date: 2006-07-27
End date: 2006-07-27
Botox
Dosage: 22 units, single
Start date: 2006-10-25
End date: 2006-10-25
Other drugs received by patient: Natrilix / 00340101 /; Diane
|
